Avadel Pharmaceuticals PLC
CIK 1012477 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Avadel Pharmaceuticals PLC.
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Feb 23, 2026 | 15-12G | 0001104659-26-018282 |
| Feb 18, 2026 | 4 | 0001357550-26-000015 |
| Feb 18, 2026 | 3 | 0001357550-26-000014 |
| Feb 17, 2026 | SCHEDULE 13G/A | 0001011438-26-000152 |
| Feb 17, 2026 | SCHEDULE 13G/A | 0001274173-26-000063 |
| Feb 13, 2026 | EFFECT | 9999999995-26-000564 |
| Feb 13, 2026 | EFFECT | 9999999995-26-000566 |
| Feb 13, 2026 | EFFECT | 9999999995-26-000565 |
| Feb 13, 2026 | EFFECT | 9999999995-26-000563 |
| Feb 12, 2026 | S-8 POS | 0001104659-26-014397 |
| Feb 12, 2026 | S-8 POS | 0001104659-26-014388 |
| Feb 12, 2026 | S-8 POS | 0001104659-26-014393 |
| Feb 12, 2026 | S-8 POS | 0001104659-26-014398 |
| Feb 12, 2026 | POSASR | 0001104659-26-014338 |
| Feb 12, 2026 | 4 | 0001104659-26-014449 |
| Feb 12, 2026 | 4 | 0001104659-26-014443 |
| Feb 12, 2026 | 4 | 0001104659-26-014447 |
| Feb 12, 2026 | S-8 POS | 0001104659-26-014376 |
| Feb 12, 2026 | S-8 POS | 0001104659-26-014389 |
| Feb 12, 2026 | S-8 POS | 0001104659-26-014394 |
| Feb 12, 2026 | POS AM | 0001104659-26-014355 |
| Feb 12, 2026 | 8-K | 0001104659-26-013880 |
| Feb 12, 2026 | POS AM | 0001104659-26-014343 |
| Feb 12, 2026 | POS AM | 0001104659-26-014341 |
| Feb 12, 2026 | S-8 POS | 0001104659-26-014391 |